PSI is a non-profit organisation formed in 1977 which provides a forum for regular discussion of statistics and issues relating to the practice of statistics in the pharmaceutical industry, as well as promoting good statistical practice within the industry.

Why join PSI


We provide...

opportunities for our members to network, develop themselves and shape the industry

We are...

run by our membership through a network of committees and special interest groups

We promote...

best statistical practice to our members and promote the value of statistics to the external world

Statisticians in the Pharmaceutical Industry
Executive Office: Durford Mill, Petersfield, Hampshire, GU31 5AZ e: PSI@MCI-group.com t: +44 (0)1730 715 235 

Latest News


Show all news

EventsFuture Events


  • Decision-making in drug development - Dates: 12 Dec, 2018

    This meeting aims to bring together statisticians from the pharmaceutical industry and academia to hear about recent advances in statistical methods for quantitative decision-making in drug development.
  • PSI Webinar: How to use prior knowledge and still give new data a chance? - Dates: 19 – 19 Dec, 2018

    The paper to be presented appeared earlier this year in Pharmaceutical Statistics (Weber, Hemmings, Koch, 17, 329-341) and is motivated by the opportunities and challenges for using Bayesian methods with informative priors to support drug development and licencing when only a small pool of patients is available, as in the case of rare diseases and paediatric population.
  • PSI Webinar: HTA Submissions in the UK - Dates: 21 – 21 Jan, 2019

    There is a simple equation for access in the UK: Access = Reimbursement + Uptake. Yet, whilst a simple and logical approach, each component is challenging to achieve. This webinar focuses on the National Reimbursement side: the National Institute for Health and Care Excellence (NICE) - who they are, what is involved in the Health Technology Appraisal (HTA) assessment, how they make decisions.
  • PSI One Day Meeting: New Emerging Topics around Estimands and ICH Addendum - Dates: 29 Jan, 2019

    The draft ICH E9 addendum on estimands and sensitivity analysis was released back in July 2017 and (more than 1000) comments are back. All stakeholders are gaining the necessary experience and familiarity with estimands along with the associated challenges and methodologies. The language and thinking behind causal inference is well suited to this area.
  • Medical Statistics Careers Event 2019 - Dates: 20 Feb, 2019

    Our annual PSI Medical Statistics Careers Event, will be held at the De Montfort University in Leicester on Wednesday 20th February 2019.
  • Network Meta Analysis (NMA) for Statisticians - Dates: 07 – 08 Mar, 2019

    This intensive course will cover all basic and advanced aspects of synthesis of evidence from studies comparing competing treatments for the same health condition. By the end of this course participants will have an understanding of the role and potential of network meta-analysis, the principles, steps and statistical methods involved; the biases that can distort indirect comparisons and network meta-analysis.
  • PSI Conference 2019 - Dates: 02 – 05 Jun, 2019

    PSI are pleased to announce that the countdown to the 2019 Conference has begun! The theme for the conference is “Data Driven Decision Making in Medical Research”. The 2019 PSI Conference will take place at the Queen Elizabeth II Centre (QEII), London, from 2nd to 5th June 2019.
  • Introduction To Industry Training Course 2019 - Dates: 01 Oct, 2019

    The ITIT course will take 25 delegates new to the industry on a complete drug development experience from discovery to marketing. They will visit 6 companies from October 2019 to July 2020 to learn about 6 topics from experts in their field. The ITIT course will have 3 sessions in continental Europe and 3 sessions in the UK. It promises to be a truly memorable course.